A research scientist at a laboratory of a pharmaceutical company in US. Reuters
Novartis is buying dry-eye medicine brand ‘Xiidra’ from Takeda Pharmaceutical for up to $5.3 billion as the Swiss pharma-maker refreshes its ophthalmic medicines portfolio with a potential blockbuster. The deal calls for $3.4 billion up front and milestone payments up to $1.9 billion, Novartis said.
South Africa’s Biovac Institute will start local production of Sanofi’s Hexaxim vaccine next year and Pfizer’s anti-pneumonia Prevnar 13 vaccine in 2021, boosting supply of life-saving drugs in its main market, its CEO said.
Swiss drugmaker Novartis on won US approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. The Food and Drug Administration approved Zolgensma for children
The Department of Health-Abu Dhabi decided to withdraw 20 batches medical products used in catheterisation and other healthcare operations from the Emirate because of their possibility of causing serious infection to patients if they were not immediately substituted with good ones.
The Opec oil-producing countries and ally Russia said on Friday they have agreed to cut their crude production by an extra 500,000 barrels a day as they try to support global energy prices.
Pakistan’s largest real estate portal, Zameen.com, successfully kicked off the third edition of its annual Pakistan Property Show (PPS) in Dubai on Friday.
The total number of international tourist arrivals to Dubai and Abu Dhabi increased to 15.88 million during the first nine months of the year, as compared to 15.26 million during the same period last year,
WTS Dhruva Consultants, a boutique tax advisory firm and FTA registered Tax Agent with presence in the UAE, Saudi Arabia and Bahrain, has published another comprehensive guide on ‘Impact of Indirect Taxes on Retail Sector